CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts
 
HE-Single Disease Content  
Recorded Educational Webinar

Webcasts
     
Hepatic Encephalopathy   Educational Webcast
Expert Insights: Improving Outcomes in Patients with Chronic Liver Disease   Educational Webcast
Complications of cirrhosis   Recorded Webinar
Clinical Insights into the Management of the Complications of Cirrhosis   CME Audiocast
Featured Resources

 
Dynamic CME Resource Library
     
Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases   Educational eNewsletter
Hepatic Encephalopathy Update: Reports from the 2013 American College of Gastroenterology Meeting   Educational eNewsletter
Hepatic Encephalopathy Update: Reports From the 2013 Digestive Disease Week Annual Meeting   Educational eNewsletter
Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference   Educational eNewsletter
Hepatic Encephalopathy: A Review of Diagnostic Methods   Educational eNewsletter
 
Slide Library
   Released: 2022
test
Expert Insights: Improving Outcomes in Patients with Chronic Liver Disease
46 slides
 
 
   Released: 2020
test
Complications of Cirrhosis
65 slides
 
 
 
 
Abstract Library
1.Lactulose therapy for patients with cirrhosis, portal hypertension, and poor patient reported outcomes - the Mi-Kristal RCT
 

Hepatology. 2023 Apr 18. doi: 10.1097/HEP.0000000000000408. Online ahead of print.

Elliot B Tapper 1, Erin Ospina, Najat Salim, Xi Chen, Samantha Nikirk
 
2.Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations
 

Dig Dis Sci. 2023 Mar;68(3):1026-1034. doi: 10.1007/s10620-022-07591-9. Epub 2022 Jul 4.

Pradeep Yarra 1, Winston Dunn 2, Zobair Younossi 3, Yong-Fang Kuo 4, Ashwani K Singal 5 6
 
3.Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial
 

EClinicalMedicine. 2023 Apr 4;58:101924. doi: 10.1016/j.eclinm.2023.101924.eCollection 2023 Apr.

Louise China 1, Thais Tittanegro 1, Dominic Crocombe 1, Ewan Forrest 2, Yiannis Kallis 3, Stephen D Ryder 4, Gavin Wright 5, Nick Freemantle 6, Alastair O'Brien 1 6
 
4.Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study
 

Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002251. Online ahead of print.

Simon Johannes Gairing 1 2, Chiara Mangini 3, Lisa Zarantonello 3, Stefania Gioia 4, Elise Jonasson Nielsen 5, Sven Danneberg 6, Maria Gabriel 7, Alena F Ehrenbauer 7, Patricia P Bloom 8, Cristina Ripoll 9 10, Philippe Sultanik 11, Peter Robert Galle 1 2, Joachim Labenz 12, Dominique Thabut 11, Alexander Zipprich 9 10, Anna S Lok 8, Karin Weissenborn 7, Jens Uwe Marquardt 6, Mette Munk Lauridsen 5, Silvia Nardelli 4, Sara Montagnese 3 13, Christian Labenz 1 2
 
5.Update in the Treatment of the Complications of Cirrhosis
 

Clin Gastroenterol Hepatol. 2023 Mar 25;S1542-3565(23)00227-6.doi: 10.1016/j.cgh.2023.03.019. Online ahead of print.

Juan G Abraldes 1, Paolo Caraceni 2, Marwan Ghabril 3, Guadalupe Garcia-Tsao 4
 
6.Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis
 

Aliment Pharmacol Ther. 2023 Mar;57(6):620-634. doi: 10.1111/apt.17344.Epub 2022 Dec 15.

Leire Leache 1 2, Marta Gutiérrez-Valencia 1 2, Luis Carlos Saiz 1 2, Juan Uriz 3, Federico Bolado 3, José Antonio García-Erce 4 5, Lorenzo Cantarelli 6, Juan Erviti 1 2
 
7.Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis
 

J Gastrointestin Liver Dis. 2023 Apr 1;32(1):70-76. doi: 10.15403/jgld-4508.

Zohaib Ahmed 1, Mona Hassan 2, Syeda Faiza Arif 3, Muhammad Aziz 4, Umair Iqbal 5, Ahmad Nawaz 6, Umer Farooq 7, Wade Lee Smith 8, Joyce Badal 9, Anas Renno 10, Toseef Javaid 11, Ali Nawras 12, Sammy Saab 13
 
8.Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy
 

Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07935-z. Online ahead of print.

Kenneth W Chow 1, Brittney M Ibrahim 2, Jung J Yum 2 3, An Dang 2, Long Dang 2, Kuan-Ting Chen 4, Nicholas J Jackson 4, Sammy Saab 5 6
 
9.Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
 

Gut. 2023 Apr;72(4):749-758. doi: 10.1136/gutjnl-2022-326975.Epub 2022 Sep 9.

Marika Rudler 1 2 3, Virginia Hernández-Gea 4, Bogdan Dumitru Procopet 5 6, Alvaro Giráldez 7, Lucio Amitrano 8, Càndid Villanueva 9 10, Luis Ibañez 11 12, Gilberto Silva-Junior 4, Joan Genesca 13, Christophe Bureau 14, Jonel Trebicka 15, Rafael Bañares 16, Aleksander Krag 17, Elba Llop 18, Wim Laleman 19, Jose Maria Palazon 20, Jose Castellote 21, Susana Rodrigues 22, Lise Lotte Gluud 23, Carlos Noronha Ferreira 24, Nouria Canete 25, Manuel Rodríguez 26, Arnulf Ferlitsch 27, Jose Luis Mundi 28, Henning Gronbaek 29, Manuel Hernandez-Guerra 30, Romano Sassatelli 31, Alessandra Dell'era 32 33, Marco Senzolo 34, Juan G Abraldes 35, Manuel Romero-Gómez 36, Alexander Zipprich 37, Meritxell Casas 38, Helena Masnou 39, Hélène Larrue 40, Massimo Primignani 41, Frederik Nevens 42, Jose Luis Calleja 43 44, Remy Schwarzer 27, Christian Jansen 45, Marie-Angèle Robic 40, Irene Conejo 46, Javier Martínez Gonzalez 47, Maria Vega Catalina 48, Agustín Albillos 49 50, Edilmar Alvarado 51, Maria Anna Guardascione 52, Maxime Mallet 53, Simona Tripon 53, Georgina Casanovas 54, Jaume Bosch 55, Juan-Carlos Garcia-Pagan 4, Dominique Thabut 53 2 3; for International Variceal Bleeding Observational Study Group: a Baveno Cooperation
 
10.Dementia Frequently Coexists With Hepatic Encephalopathy but Not Other Cirrhosis Complications in US Veterans
 

Am J Gastroenterol. 2023 Mar 1;118(3):475-480. doi: 10.14309/ajg.0000000000002189.Epub 2023 Jan 17.

Adeyinka Adejumo 1, Alan Noll 1, Shari S Rogal 1 2, Vera Yakovchenko 2, Linda Chia 3, Patrick Spoutz 4, Timothy R Morgan 5, Jasmohan S Bajaj 6 7
 
11.Hepatic encephalophaty: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3)
 

Minerva Med. 2023 Mar 23. doi: 10.23736/S0026-4806.22.08408-7. Online ahead of print.

Gianni Testino 1, Luigi C Bottaro 2, Enzo Andorno 3, Fabio Bandini 4, Patrizia Balbinot 5, Sabrina Beltramini 6, Simona Bottino 7, Marta Caltabellotta 8, Fabio Caputo 9 10 11 12, Enrica Caviglia 13, Pierfrancesco Curone 14, Antonio DI Biagio 15, Carmelo Gagliano 16, Nicoletta Gandolfo 14, Luca Pestarino 17, Alessandro Rollero 18, Emanuele Romairone 19, Lorenzo Sampietro 20, Enrico Torre 21, Silvia Zuccarelli 22, Rinaldo Pellicano 23
 
12.Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
 

Hepatol Commun. 2023 Mar 17;7(4):e0096. doi: 10.1097/HC9.0000000000000096.eCollection 2023 Apr 1.

Simon J Gairing 1 2, Eva M Schleicher 1 2, Peter R Galle 1 2, Christian Labenz 1 2
 
13.Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival
 

Transplantation. 2023 Feb 1;107(2):410-419. doi: 10.1097/TP.0000000000004303.Epub 2023 Jan 26.

Ilias Kounis 1 2 3 4, Mylène Sebagh 2 3 4 5, Manon Evain 1, Valérie Cailliez 1 2 3 4, Bruno Roche 1 2 3 4, Eleonora De Martin 1 2 3 4, Rodolphe Sobesky 1 2 3 4, Catherine Guettier 2 3 4 5, Marc Antoine Allard 1 2 3 4, Nicolas Golse 1 2 3 4, Daniel Azoulay 1 2 3 4, Eric Vibert 1 2 3 4, Jean Charles Duclos Vallee 1 2 3 4, Cyrille Feray 1 2 3 4, Didier Samuel 1 2 3 4, Audrey Coilly 1 2 3 4
 
14.Gut microbiome-brain-cirrhosis axis
 

Hepatology. 2023 Mar 6. doi: 10.1097/HEP.0000000000000344. Online ahead of print.

Maren L Smith 1 2, James B Wade 3, Jennifer Wolstenholme 1 2, Jasmohan S Bajaj 4
 
15.Reduction in Gastrointestinal Cancers in Cirrhotic Patients Receiving Rifaximin vs Lactulose Only Therapy for Hepatic Encephalopathy
 

Cureus. 2023 Feb 21;15(2):e35259. doi: 10.7759/cureus.35259. eCollection 2023 Feb.

Ankoor H Patel 1, You Li 2, Carlos D Minacapelli 2, Kaitlyn Catalano 2, Vinod Rustgi 2
 
16.Novel Innovations in Ascites Management
 

S D Med. 2023 Mar;76(3):116-119.

Kyle McKenna Siemers 1, Joel Dan Stjernholm 2, Christine Pocha 1 3
 
17.Active Clinical Trials in Hepatic Encephalopathy: Something Old, Something New and Something Borrowed
 

Neurochem Res. 2023 Mar 28;1-11. doi: 10.1007/s11064-023-03916-w.Online ahead of print.

Tiziano Balzano 1
 
18.Hepatic Encephalopathy: Diagnostic Tools and Management Strategies
 

Med Clin North Am. 2023 May;107(3):517-531. doi: 10.1016/j.mcna.2023.01.003.Epub 2023 Feb 20.

Bryan D Badal 1, Jasmohan S Bajaj 2
 
19.Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study
 

Hepatol Commun. 2023 Feb 1;7(2):e0002. doi: 10.1097/HC9.0000000000000028.

Adam Buckholz 1, Lindsay Clarke 2, Paul Paik 2, Arun Jesudian 1, Robert Schwartz 1, Ana Krieger 3, Russell Rosenblatt 1, Robert S Brown Jr 1
 
20.Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy
 

Am J Gastroenterol. 2023 Feb 1;118(2):284-293.doi: 10.14309/ajg.0000000000002008. Epub 2022 Aug 22.

Andrew M Moon 1, Hannah P Kim 2, Yue Jiang 3, Gabriel Lupu 4, Jennifer S Bissram 5, A Sidney Barritt 4th 1, Elliot B Tapper 6 7
 
21.A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study
 

Hepatol. 2023 Feb;78(2):312-321.doi: 10.1016/j.jhep.2022.09.009. Epub 2022 Sep 22.

Andrew Fagan 1, Edith A Gavis 1, Mary Leslie Gallagher 1, Travis Mousel 1, Brian Davis 1, Puneet Puri 1, Richard K Sterling 1, Velimir A Luketic 1, Hannah Lee 1, Scott C Matherly 1, Arun J Sanyal 1, R Todd Stravitz 1, Vaishali Patel 1, Mohammad S Siddiqui 1, Amon Asgharpour 1, Michael Fuchs 1, Leroy Thacker 2, Jasmohan S Bajaj 3
 
22.Hepatic encephalopathy - recent advances in treatment and diagnosis
 

Expert Rev Gastroenterol Hepatol. 2023 Mar;17(3):225-235.doi: 10.1080/17474124.2023.2183386. Epub 2023 Feb 26.

Silvia Nardelli 1, Stefania Gioia 1, Jessica Faccioli 1, Oliviero Riggio 1, Lorenzo Ridola 1
 
23.Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
 

J Clin Med. 2023 Feb 2;12(3):1187. doi: 10.3390/jcm12031187.

Daniele Bellafante 1, Stefania Gioia 1, Jessica Faccioli 1, Oliviero Riggio 1, Lorenzo Ridola 1, Silvia Nardelli 1
 
24.Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
 

J Hepatol. 2020 Dec;73(6):1526-1547. doi: 10.1016/j.jhep.2020.07.013.Epub 2020 Oct 21.

Christopher F Rose 1, Piero Amodio 2, Jasmohan S Bajaj 3, Radha Krishan Dhiman 4, Sara Montagnese 2, Simon D Taylor-Robinson 5, Hendrik Vilstrup 6, Rajiv Jalan 7
 
25.Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
 

J Hepatol. 2020 Dec;73(6):1526-1547. doi: 10.1016/j.jhep.2020.07.013.Epub 2020 Oct 21.

Christopher F Rose 1, Piero Amodio 2, Jasmohan S Bajaj 3, Radha Krishan Dhiman 4, Sara Montagnese 2, Simon D Taylor-Robinson 5, Hendrik Vilstrup 6, Rajiv Jalan 7
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.